A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α

A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α

The endocannabinoid 2-arachidonoylglycerol (2-AG) is predominantly biosynthesized by sn-1-diacylglycerol lipase α (DAGL-α) in the CNS. Selective inhibitors of DAGL-α will provide valuable insights in the role of 2-AG in endocannabinoid signaling processes and are potential therapeutics for the treat...

Full description

Bibliographic Details
Main Authors:	Tom van der Wel, Freek J. Janssen, Marc P. Baggelaar, Hui Deng, Hans den Dulk, Herman S. Overkleeft, Mario van der Stelt
Format:	Article
Language:	English
Published:	Elsevier 2015-04-01
Series:	Journal of Lipid Research
Subjects:	2-arachidonoylglycerol cannabinoids endocannabinoid enzymology lipids obesity
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520355735

Similar Items

Inhibition of diacylglycerol lipase β modulates lipid and endocannabinoid levels in the ex vivo human placenta
by: Natascha Berger, et al.
Published: (2023-02-01)

Diacylglycerol lipase a knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice
by: David R Powell, et al.
Published: (2015-06-01)

Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice
by: Victoria S. Cavener, et al.
Published: (2018-07-01)

Localization of diacylglycerol lipase alpha and monoacylglycerol lipase during postnatal development of the rat retina
by: Bruno eCécyre, et al.
Published: (2014-12-01)

Identification of α,β-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells
by: Annelot C. M. van Esbroeck, et al.
Published: (2019-11-01)

Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity
by: Isabel Baenas, et al.
Published: (2023-01-01)

Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case–control study
by: Hadi Bazyar, et al.
Published: (2022-11-01)

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
by: Stefania Petrosino, et al.
Published: (2019-12-01)

Human Milk Endocannabinoid Levels as a Function of Obesity and Diurnal Rhythm
by: Palika Datta, et al.
Published: (2021-07-01)

The endocannabinoid system: an overview
by: Natalia eBattista, et al.
Published: (2012-03-01)

Endocannabinoids, Related Compounds and Their Metabolic Routes
by: Filomena Fezza, et al.
Published: (2014-10-01)

Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs[S]
by: Antoni Pastor, et al.
Published: (2014-05-01)

Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats
by: Aidan Levine, et al.
Published: (2021-11-01)

Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia
by: Tibor Stark, et al.
Published: (2022-01-01)

Alterations in Rat Accumbens Dopamine, Endocannabinoids and GABA Content During WIN55,212-2 Treatment: The Role of Ghrelin
by: Chrysostomos Charalambous, et al.
Published: (2020-12-01)

Endocannabinoid 2-Arachidonoylglycerol Levels in the Anterior Cingulate Cortex, Caudate Putamen, Nucleus Accumbens, and Piriform Cortex Were Upregulated by Chronic Restraint Stress
by: Qing Zhai, et al.
Published: (2023-01-01)

Critical role of the endocannabinoid system in mediating rapid glucocorticoid effects on memory for emotionally arousing experiences
by: Benno Roozendaal
Published: (2012-09-01)

Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
by: Kazuhito Tsuboi, et al.
Published: (2018-10-01)

Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study
by: Elettra Febo, et al.
Published: (2021-05-01)

The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
by: Martina Rabino, et al.
Published: (2021-09-01)

Contribution of diacylglycerol lipase β to pain after surgery
by: Luk J, et al.
Published: (2018-03-01)

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
by: Daniel A. Ladin, et al.
Published: (2016-10-01)

2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus
by: Luca Navarini, et al.
Published: (2022-07-01)

The effects of exercise on circulating endocannabinoid levels—a protocol for a systematic review and meta-analysis
by: Viviane Bristot, et al.
Published: (2022-05-01)

Genetic variation of the 5‐HT1A rs6295, 5‐HT2A rs6311, and CNR1 rs1049353 and an altered endocannabinoid system in depressed patients
by: Jasmin Obermanns, et al.
Published: (2023-12-01)

Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca2+-binding proteins calbindin, calretinin and parvalbumin in the adult rat hippocampus
by: Patricia eRivera, et al.
Published: (2014-06-01)

Bidirectional regulation of endocannabinoid signaling in the amygdala contributes to activation and adaptation of the stress response
by: Matthew N. Hill
Published: (2012-09-01)

Anandamide Metabolites Protect against Seizures through the TRP Channel Water Witch in Drosophila melanogaster
by: Jack A. Jacobs, et al.
Published: (2020-06-01)

Endocannabinoids in stressed humans
by: Gustav Schelling
Published: (2012-09-01)

Enzymatic hydrolysis of fats at high substrate concentrations in biphasic organic-aqueous systems/
by: Mukataka, Sukekuni, et al.

The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
by: Wujood Khayat, et al.
Published: (2022-06-01)

Chemism and the role of endocannabinoids in physiological processes
by: Prerad Ranka, et al.
Published: (2017-01-01)

Potential of Endocannabinoids to Control Bladder Pain
by: Dale E. Bjorling, et al.
Published: (2018-05-01)

Lower circulating endocannabinoid levels in children with autism spectrum disorder
by: Adi Aran, et al.
Published: (2019-01-01)

Activity-Dependent Modulation of Tonic GABA Currents by Endocannabinoids in Hirudo verbana
by: Riley T. Paulsen, et al.
Published: (2022-03-01)

Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions
by: Tapan Behl, et al.
Published: (2020-08-01)

Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
by: Justin Matheson, et al.
Published: (2021-12-01)

New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling
by: Agustín Riquelme-Sandoval, et al.
Published: (2020-12-01)

The potential role of cannabinoids in dermatology
by: Tabrez Sheriff, et al.
Published: (2020-11-01)

Cannabinomimetric Lipids: From Natural Extract to Artificial Synthesis
by: Ya-Ru Gao, et al.
Published: (2018-01-01)